Thursday, November 14, 2019

Hundreds of governmental entities have begun the process of suing wholesale distributors and manufacturers of opioids seeking reimbursement for government spending arising out of opioid addictions and overdoses.

The defendants often include companies such as McKesson Corporation, Cardinal Health, AmerisourceBergen, Purdue Pharma, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Endo International, Teva Pharmaceutical, Allergan (formerly Actavis), Watson Pharmaceuticals, and Covidien.

The complaints typically allege the wholesale distributors violated the federal Controlled Substances Act by failing to alert the U.S. Drug Enforcement Administration of suspicious opioids purchases, such as orders of unusual size, frequency or pattern. The claims against the manufacturers are based on allegations the companies exaggerated the benefits of the medication and knew the drugs were being overly prescribed, yet failed to warn doctors of the extremely addictive nature of the narcotics and the need to strictly limit the dose.

Below are the news stories and videos we have posted on this topic.

Opioid News

Top Insys Therapeutics Executives Found Guilty on Federal Racketeering Charges

After a ten-week-long trial, the former billionaire founder of Insys Therapeutics, John Kapoor, was found guilty this past week of bribing physicians and lying to insurance companies in order to drive and maximize sales of the company's highly addictive fentanyl-based pain medication, Subsys. Four other top-level company executives were also found guilty. The...

Fentanyl: The Deadliest Opioid, Says CDC

Among the ten most frequently mentioned drugs in reports on overdose fatalities, the synthetic opioid fentanyl leads the way. This is according to a recent report published by the Centers for Disease Control. From 2011 through 2016, the number of fentanyl-related deaths rose by a whopping 1,000 percent. Prior to 2016,...

Once Considered a Rural Phenomenon, the Opioid Epidemic Moves Into Eastern Cities

Since awareness of the issue of opioid addiction began to reach public consciousness in the late 1990s, opioid addiction has been seen as a largely rural problem affecting whites of lower socio-economic status (SES). Increasingly, this is no longer the case. A study published last Friday in the Journal of the American...

The Opioid Epidemic is Resulting in More Infection Related Strokes

Earlier this week, a prominent vascular neurologist who spoke at the recent annual conference of the American Stroke Association shared a grim report: opioid abuse is driving a rise in the number of strokes. Dr. Setareh Salehi Omran, lead author of a study soon to be published in the journal Stroke,...

The Alarming Increase in Opioid Overdose Fatalities Among Middle-Aged Women

This week, the Centers for Disease Control and Prevention released a disturbing report about the nation's current opioid crisis. It appears that the fastest growing number of fatal opioid overdoses is among women between the ages of 30 and 64. According to the report, the annual drug overdose death rate in general...

Judge Says Big Pharma Doesn’t Have To Pay For Opioid Epidemic In New York

A judge in Manhattan has blocked an effort by lawmakers to make drug manufacturers and distributors pay for the costs of cleaning up the opioid epidemic that they created. The judge said that these drug makers can’t be held financially liable because that would violate the commerce...

As the Nation Struggles With an Addiction Epidemic, the FDA Approves a New Opioid-Based Pain Medication

Just before the weekend, the U.S. Food and Drug Administration gave its approval for a new, powerful and fast-acting opioid medication, despite serious concerns that it will only add to the current addiction crisis.  The product, manufactured by small San Francisco-area pharmaceutical company, was approved by an FDA committee...

Proposed Oregon Law Would Ban Medicaid Coverage of Opioids After One Year of Use

In Oregon, usually one of the more progressive states in terms of social policy, lawmakers in Salem are considering legislation that would end all Medicaid coverage for prescription opioids.  Under the proposed statute, patients who depend on opioid-based medication for chronic pain management would have twelve months to taper off their...

Oxycontin Makers Will Not Market To Doctors Anymore

The maker of Oxycontin has said that they'll no longer market their opioids directly to doctors. Ring of Fire’s Mike Papantonio and attorney Peter Mougey discuss this issue.Transcript:Mike Papantonio: The maker of Oxycontin has said that they'll no longer market their opioids directly to doctors. This move isn't because...

The Company Responsible for the Opioid Crisis Now Wants to Profit From Fixing It

Purdue Pharma, the company that brought us OxyContin and has been targeted in lawsuits by several states over its role in causing the opioid addiction crisis, now has an opportunity to profit from providing a solution.Just before the weekend, the Financial Times broke the story that Purdue was granted...
Opioid Videos